Chen S, Wang H, Ning B. A case report of acute myocardial infarction with extremely severe thrombocytopenia after percutaneous coronary intervention.
Medicine (Baltimore) 2023;
102:e35971. [PMID:
37960787 PMCID:
PMC10637503 DOI:
10.1097/md.0000000000035971]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Accepted: 10/16/2023] [Indexed: 11/15/2023] Open
Abstract
INTRODUCTION
The case report's purpose is to remind doctors a rare complication named thrombocytopenia of antithrombotic drugs. As a result, severe bleeding or even life-threatening situations may be avoided.
PATIENT CONCERNS
A specific case of a patient with acute myocardial infarction, a significant decrease in platelet count was observed after percutaneous coronary intervention.
DIAGNOSIS
After ruling out other potential causes, the medical team considered tirofiban-induced thrombocytopenia as a possible explanation.
INTERVENTIONS AND OUTCOMES
Through careful monitoring and adjustment of medication, the patient's platelet count eventually returned to normal.
CONCLUSION
To ensure patient safety, it is advised to regularly monitor platelet counts at intervals of 2 to 6 hours before and after administering tirofiban.
Collapse